The colocalization coefficient of microglia with the M1 marker CD86 was significantly higher in the AD group than in the US group (66.4% ± 7.78% vs. 52.5% ± 5.19%, p < 0.01; Figure 2A,B). This evidence concerns the gene CD86 and Alzheimer disease.